Patients awaiting open heart surgery.
Conditions
Interventions
Intervention 1: Intervention group: Receive an ultrasound-guided erector spina thoracosa (ESP) muscle block with an injection of 20 mL of 0.25% bupivacaine. Intervention 2: Control group: Implementing
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 76 Years
Inclusion criteria
Inclusion criteria: All people over the age of 18 and under the age of 76 No history of addiction or drug use No history of addiction or use of painkillers. No history of rheumatological (musculoskeletal) diseases Non-sensitivity to the study drug and anesthetic drugs
Exclusion criteria
Exclusion criteria: Refusal to participate in research Inability to assess pain level Allergy to study drugs and anesthetics Morbid obesity (body mass index > 45)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Lvel of pain based on Numeric Rating Scale. Timepoint: After surgery. Method of measurement: Numeric Rating Scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| Respiratory adequacy based on arterial blood gas analysis. Timepoint: After open heart surgery. Method of measurement: Analysis based on arterial blood gas testing. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactSheyda Piroozeh
Babol University of Medical Sciences
Outcome results
None listed